Canadian medicinal cannabis prescriptions jump 35% amid retail sales surge

Prescription growth coincides with record retail sales, signaling expanding medical-use segment alongside recreational market.

FILE — harvest · My 420 Tours / CC BY-SA 4.0

Medicinal cannabis prescriptions in Canada rose 35%, according to reporting from Yahoo News Canada. The timing aligns with broader cannabis market expansion: retail sales hit a record $517.7 million in June 2026, according to StratCann data, and the sector continues to post solid quarterly earnings across major producers.

The prescription increase suggests growing physician and patient acceptance of cannabis for medical purposes, separate from recreational demand. This divergence may reflect maturing clinical discussion and possible prescription-writing confidence as the market stabilizes beyond early-stage adoption.

Watch whether the medicinal uptick sustains as a distinct growth driver or converges with recreational demand patterns. Provincial licensing and insurance coverage shifts could signal whether this segment becomes a structural, reportable channel within Canada's cannabis revenue mix.